Talsaclidine

Talsaclidine
Systematic (IUPAC) name
	(3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane
Clinical data
Pregnancy cat.	?
Legal status	?
Pharmacokinetic data
Bioavailability	70%
Protein binding	7%
Excretion	Renal (86%)
Identifiers
CAS number	147025-53-4
ATC code	None
PubChem	CID 71792
ChemSpider	64819
UNII	1O8VSL798T
Chemical data
Formula	C10H15NO
Mol. mass	165.23 g/mol
SMILES	eMolecules & PubChem

[edit] See also

^ Ensinger HA, Doods HN, Immel-Sehr AR, et al. (1993). "WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties". Life Sciences 52 (5-6): 473–80. doi:10.1016/0024-3205(93)90304-L. PMID 8441328.
^ Walland A, Burkard S, Hammer R, Tröger W (1997). "In vivo consequences of M1-receptor activation by talsaclidine". Life Sciences 60 (13-14): 977–84. doi:10.1016/S0024-3205(97)00037-4. PMID 9121364.
^ ^a ^b Wienrich M, Meier D, Ensinger HA, et al. (April 2001). "Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man". Life Sciences 68 (22-23): 2593–600. doi:10.1016/S0024-3205(01)01057-8. PMID 11392631.
^ Terry AV, Buccafusco JJ, Borsini F, Leusch A (July 2002). "Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine". Psychopharmacology 162 (3): 292–300. doi:10.1007/s00213-002-1105-3. PMID 12122487.
^ Adamus WS, Leonard JP, Tröger W (1995). "Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease". Life Sciences 56 (11-12): 883–90. doi:10.1016/0024-3205(95)00024-Z. PMID 10188789.